Edition:
United States

Novogen Ltd (NVGN.OQ)

NVGN.OQ on NASDAQ Stock Exchange Capital Market

3.12USD
19 Sep 2017
Change (% chg)

$-0.01 (-0.32%)
Prev Close
$3.13
Open
$3.09
Day's High
$3.15
Day's Low
$3.09
Volume
925
Avg. Vol
1,850
52-wk High
$8.32
52-wk Low
$2.67

Latest Key Developments (Source: Significant Developments)

Novogen posts FY loss of $10.7 mln
Tuesday, 29 Aug 2017 06:15pm EDT 

Aug 30 (Reuters) - Novogen Ltd :Novogen reported FY loss of $10.7 million versus loss of $12.1 million last year.FY revenues from ordinary activities down 38.7% to $248.8 million.  Full Article

Novogen Ltd provides update to investors on a review of business operations
Monday, 14 Aug 2017 06:00am EDT 

Aug 14 (Reuters) - Novogen Ltd :Novogen Ltd - provide an update to investors on a review of business operations recently completed by board and management team.Novogen Ltd - directors have offered to reduce their fees, providing additional savings to company.Novogen Ltd - annual cost of board has been reduced by approximately 50%..Novogen - about $1.8 million of annualized savings identified in operating expenses, principally comprising reduction in consultant expenditure, reduction in headcount.  Full Article

Novogen says chairman John O'connor to step down
Wednesday, 7 Jun 2017 08:04pm EDT 

June 8 (Reuters) - Novogen Ltd -:Chairman, john o'connor and non-executive director, ian phillips step down from novogen board.Iain ross appointed chairman.James garner continues as ceo and executive director."Following a review of novogen's fixed cost base, further savings have been identified in general and administrative expense budgets"​."‍expected that these funds will be re-directed to support development of novogen's clinical assets"​.  Full Article

Novogen says CFO Cristyn Humphreys will leave company
Thursday, 9 Mar 2017 05:42pm EST 

Novogen Ltd : Cristyn Humphreys, chief financial officer (CFO) at Novogen will leave Novogen later this month to assume a new role outside industry . Andrew Heaton, CEO of Novogen North America, will leave Novogen .Transition of CFO will be overseen by Kate Hill, formerly a partner at Deloitte, who currently serves as company secretary.  Full Article

Novogen awarded grant for novel drug discovery
Wednesday, 8 Feb 2017 05:37pm EST 

Novogen Ltd - :Novogen awarded grant of up to $3mln for novel drug discovery.  Full Article

Novogen submits IND application for Cantrixil
Thursday, 11 Aug 2016 07:00am EDT 

Novogen Ltd : Novogen submits Investigational New Drug (IND) Application to the U.S. FDA for Cantrixil(TM) in ovarian cancer .Expect to initiate Cantrixil IND study in last quarter of 2016.  Full Article

Novogen Appoints Dr James Garner as Chief Executive Officer
Wednesday, 9 Dec 2015 04:59pm EST 

Novogen Limited:Says appointment of Dr James Garner as Chief Executive Officer.Garner will take up the role on Feb. 1, 2016, at which time he will be appointed to the Board of Directors of Novogen.  Full Article

BRIEF-Novogen posts FY loss of $10.7 mln

* Novogen reported FY loss of $10.7 million versus loss of $12.1 million last year